Global Information
회사소개 | 문의 | 비교리스트

종양 면역치료 분야의 신규 기업

Immunotherapy in Oncology Startup Identification

리서치사 KnowMade
발행일 2020년 06월 상품 코드 942684
페이지 정보 영문 280+ Slides
가격
EUR 1,990 ₩ 2,746,000 PDF by Email (Multi-user License)


종양 면역치료 분야의 신규 기업 Immunotherapy in Oncology Startup Identification
발행일 : 2020년 06월 페이지 정보 : 영문 280+ Slides

종양 면역치료 시장은 2019-2026년 9.6%의 CAGR로 계속 성장하며, 1,269억 달러에 달할 전망입니다. 이 분야에서는 현재 연구개발이 활발하게 진행되고 있으며, 세계에서 매년 1,700만 명이 새로 이환하는 등 환자 수의 증가로 인해 많은 신규 기업이 탄생하고 있으나, 규모가 작고 기술적으로도 다양하므로 웹 검색 및 워크샵 등의 방법으로 신규 기업을 찾는 것은 어렵습니다.

종양 면역치료 관련 특허를 조사했으며, 2010-2019년 설립된 110 이상의 신규 기업을 식별하고 그 중 약 50사의 주요 활동, 제품, 특허, 주요인물 데이터를 정리하여 전해드립니다.

서론

  • 리포트의 목적
  • 조사 범위

조사 방법

  • 특허 검색, 선택, 분석
  • 검색 전략
  • 특허 분석의 용어
  • 세분화

개요

  • 신규 기업 지도제작
  • 주요 사실
  • 기타 신규 기업

신생 기업

KNOWMADE 소개

KSA 20.07.01

What are the startups that have emerged in Onco-Immunotherapy? What are they working on? Who are the key people in these companies?

Report's Key Features:

  • PDF with > 280+ slides
  • Identification & mapping of the startups that recently started to work in the field of Onco-Immunotherapy.
  • Segmentation by technology (Immune check point inhibitor, Adoptive cell transfer, Bispecific antibody, Vaccine etc.)
  • Description of the startups and their pipeline, funding rounds and subsidies.
  • Presentation of all their published patent families.
  • Description of key people and their background.

Over 110 startups working in the field of Onco-Immunotherapy were identified

Cancer Immunotherapy is a very dynamic technological field and the global market is expected to grow and reach US$ 126.9 billion by 2026, with a CAGR of 9.6% from 2019 to 2026 (Grand View Research). With an increasing number of people with cancer (17 million of new cases of cancer worldwide) and the need of new treatments, the immunotherapy domain sees the arrival of numerous startups every year. In this highly diverse and rapidly changing ecosystem, it is crucial to identify new players and monitor their activities to determine opportunities, threats, potential partnerships and collaborations. Because of their small size and technological diversity, these young companies are hard to identify by conventional approaches (web searches, workshops etc.). In this report, Knowmade has therefore investigated Onco-Immunotherapy-related patents in order to identify startups through their patent filings. More than 110 startups incorporated between 2010 and 2019 were thus identified, and for over 50 of them, the report describes their main activity, products, patents, and key people among their staff. This study reveals that Cell Adoptive Transfer (e.g. CAR-T cell) is by far the technology explored the most by startups working in the field of immunotherapy in oncology. Immune checkpoint inhibitor/modulator, bispecific antibody and vaccine are also technologies of interest for some startups identified.

  • Detecting hidden companies - Looking at patent documents makes it possible to identify companies that do not communicate much or even at all. It is a good way to detect companies that could not be found using more conventional methods (e.g. trade fairs, conferences, web searches, etc.).
  • Assessing the technology - Technology is one of the keys to a startup's success and being able to understand and assess it is highly valuable. The specification of a patent document includes a lot of technical information that can be used to determine the advantages brought by new inventions. The patent claims can also be used to determine the protection the applicant is asking for, and therefore where its interest resides.
  • Identifying the key people - The success of a startup is strongly linked to the team that composes it. It is therefore important to know the founders and inventors to assess the odds of its success. Patents enable the identification of inventors inside the companies. These inventors are technical experts who have laid the foundation of the technology the startup is developing. Describing the background of key people can help in understanding the startup project, and their history can reveal the extent of the know-how they have accumulated.

Startup Identification

Startups have been identified by screening the patent documents published in 2019/2020 claiming Immunotherapy in Oncology. For each startup identified, the report provides a complete description of its activity and pipeline, with a link for ongoing clinical trials. Information about funding rounds and subsidies are also described.

Patent Description

This report includes a detailed description of all the patents filed by identified startups. The elements provided in each overview slide provide essential information to quickly understand the patented technology. For each patent family described, the publication number of Granted/Registered and Pending members are provided, as well as the abstract, the first claim, relevant information about the invention and the most relevant figure explaining how the invention can be carried out.

Key People Description

This report includes a description of the key people and/or inventors involved in each selected startup. Knowing the key people behind a startup helps assessing its chances of success by determining their individual strength and their complementarity. This report is focused on the description of the people who have a technical background. For each key person, the report shows a summary of their educational background, employment history, as well as their other current activities and a link to their LinkedIn profiles.

TABLE OF CONTENTS

INTRODUCTION

  • Objectives of the report
  • Scope of the report

METHODOLOGY

  • Patent search, selection and analysis
  • Search strategy
  • Terminologies for patent analysis
  • Segmentation

EXECUTIVE SUMMARY

  • Startups mapping
  • Key facts
  • Other startups

NEW STARTUPS

  • Startup 1
  • Startups 2 to 57
  • Startup

KNOWMADE PRESENTATION

Back to Top
전화 문의
F A Q